Is Nipple-Sparing Mastectomy Oncologically Safe in Early-Stage Breast Cancer Surgery?

Surgery is the foundation of treatment, particularly in early-stage breast cancer, the most common cancer in women. The breast is an important organ for women cosmetically, sexually, and in motherhood. Advances in techniques have therefore made breast surgery progressively less extensive. While radical methods removing the entire breast were frequently preferred in the past, they are now less favored, and methods preserving the breast skin and/or nipple are often preferred unless contraindications exist. In nipple-sparing mastectomy, one of these methods, breast tissue is removed but the breast skin and nipple remain. Cosmetic surgery (reconstruction) then provides a better cosmetic result. However, concerns arise because breast tissue that may remain could provide a potential haven for future cancers. Many studies have therefore investigated recurrence after nipple-sparing mastectomy to assess its safety. A study (meta-analysis) compiling and analyzing data from 18 separate studies published on the subject in recent years was presented at the annual meeting of the American Society of Breast Surgeons, one of the world's leading organizations.
The study followed patients, mostly with stage 1 disease, who underwent nipple-sparing mastectomy: 2332 breast cancer patients were monitored for an average of 45 months. Approximately %96 remained alive during this period (overall survival), %91 experienced no progression or deterioration (disease-free survival), and only %1,3 had locoregional recurrence. Nipple-sparing mastectomy was thus concluded to be safe in these patients. The study also compared patients undergoing nipple-sparing mastectomy solely for treatment with those undergoing it for treatment or prevention. Among patients treated solely for therapeutic purposes, overall survival was %93, disease-free survival % 84.2, and locoregional recurrence %2,6; among those undergoing it for treatment or prevention, the corresponding rates were %99, %96.2, and %0,4. As expected, preventive mastectomy thus increases overall and disease-free survival rates and reduces locoregional recurrence risk. (Preventive mastectomy: removal of the breasts to prevent cancer in people identified through genetic testing as having a high breast cancer risk or with a high incidence of breast cancer in their family.)
In conclusion; this is an important study indicating that nipple-sparing mastectomy is as safe as radical methods removing the entire breast in early-stage breast cancer patients meeting certain criteria. Of course, this study alone will not be sufficient to dispel oncologists' concerns about nipple-sparing mastectomy. As the research team also states, these results need confirmation in well-designed, comprehensive studies.
In a subsequent article we are preparing for publication, we will share answers to the questions: "Who should undergo breast-conserving surgery, who should undergo nipple-sparing surgery, and who should undergo skin-sparing mastectomy?"
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.